- Home
- BIVI vs GEG Comparison
BIVI vs GEG Comparison
Compare BIVI & GEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIVI
- GEG
- Stock Information
- Founded
- BIVI 2013
- GEG 1994
- Country
- BIVI United States
- GEG United States
- Employees
- BIVI N/A
- GEG 31
- Industry
- BIVI Biotechnology: Pharmaceutical Preparations
- GEG Computer Software: Prepackaged Software
- Sector
- BIVI Health Care
- GEG Technology
- Exchange
- BIVI Nasdaq
- GEG Nasdaq
- Market Cap
- BIVI 49.8M
- GEG 55.6M
- IPO Year
- BIVI N/A
- GEG N/A
- Fundamental
- Price
- BIVI $1.90
- GEG $1.90
- Analyst Decision
- BIVI Strong Buy
- GEG
- Analyst Count
- BIVI 1
- GEG 0
- Target Price
- BIVI $30.00
- GEG N/A
- AVG Volume (30 Days)
- BIVI 1.5M
- GEG 51.2K
- Earning Date
- BIVI 02-11-2025
- GEG 02-11-2025
- Dividend Yield
- BIVI N/A
- GEG N/A
- EPS Growth
- BIVI N/A
- GEG N/A
- EPS
- BIVI N/A
- GEG N/A
- Revenue
- BIVI N/A
- GEG $18,516,000.00
- Revenue This Year
- BIVI N/A
- GEG N/A
- Revenue Next Year
- BIVI N/A
- GEG N/A
- P/E Ratio
- BIVI N/A
- GEG N/A
- Revenue Growth
- BIVI N/A
- GEG 83.09
- 52 Week Low
- BIVI $1.04
- GEG $1.70
- 52 Week High
- BIVI $33.10
- GEG $2.12
- Technical
- Relative Strength Index (RSI)
- BIVI 30.38
- GEG 69.01
- Support Level
- BIVI $2.41
- GEG $1.76
- Resistance Level
- BIVI $2.70
- GEG $1.88
- Average True Range (ATR)
- BIVI 0.23
- GEG 0.04
- MACD
- BIVI -0.12
- GEG 0.01
- Stochastic Oscillator
- BIVI 0.00
- GEG 100.00
About BIVI BioVie Inc.
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.
About GEG Great Elm Group Inc.
Great Elm Group Inc operates as an alternative asset manager focused on growing a scalable and diversified portfolio of long-duration and permanent capital vehicles across credit, real estate, specialty finance, and other alternative strategies. Along with its subsidiaries, it manages Great Elm Capital Corp, a publicly traded business development company, and Monomoy Properties REIT, LLC, an industrial-focused real estate investment trust, in addition to other investments.